PayerIQ
Production
Back to universe
Tier 4MTPBM

InfuSystem Holdings

Deprioritize — minimal contact + revisit annually

Composite
38.0
Rank
#249
Members
11.3M
Scoring profile

Six-criterion radar

Breakdown

Weighted score contribution

Claims
25%
50
+12.5
Lives
20%
10
+2.0
Geography
20%
23
+4.6
Restrictions
15%
38
+5.7
Relationship
10%
61
+6.1
Financials
10%
71
+7.1
Composite Score38.0
Composite = Claims×0.25 + Lives×0.20 + Geography×0.20 + Restrictions×0.15 + Relationship×0.10 + Financials×0.10
= 12.5 + 2.0 + 4.6 + 5.7 + 6.1 + 7.1 = 38.0
Intelligence

Qualitative intelligence

Members
11.3M
Drug spend
$4.0B
Formulary
6-tier
PA / RA level
Moderate
Biosimilar policy
No policy defined
Avg reimbursement
62 days
Strategic notes

Restrictive formulary; outcomes-based arrangement may unlock Tier 2 placement

Playbook · Tier 4

Engagement timeline

Annually
Maintenance review · revisit tier